Abstract
Solid tumors of the pancreas encompass a variety of diagnoses with treatments ranging from observation to major abdominal surgery. Pancreatic ductal adenocarcinoma remains one of the most common and most lethal of these differential of diagnoses and requires a multimodality approach through a multidisciplinary team of specialists. This article reviews the classification, clinical presentation, and workup in differentiating solid tumors of the pancreas and serves as an additional tool for general surgeons faced with such a clinical finding, from a surgical oncology perspective.
Keywords:
Adenocarcinoma; Mass; Neoplasm; Pancreas; Pancreatectomy.
Copyright © 2020 Elsevier Inc. All rights reserved.
MeSH terms
-
Carcinoma, Pancreatic Ductal / diagnosis
-
Carcinoma, Pancreatic Ductal / mortality
-
Carcinoma, Pancreatic Ductal / pathology
-
Carcinoma, Pancreatic Ductal / surgery*
-
Cholangiopancreatography, Endoscopic Retrograde
-
Diagnosis, Differential
-
Early Detection of Cancer
-
Endosonography
-
Humans
-
Lymphoma / diagnosis
-
Lymphoma / pathology
-
Lymphoma / surgery*
-
Magnetic Resonance Imaging
-
Neoplasm Staging
-
Neuroendocrine Tumors / diagnosis
-
Neuroendocrine Tumors / mortality
-
Neuroendocrine Tumors / pathology
-
Neuroendocrine Tumors / surgery*
-
Pancreatectomy / methods
-
Pancreatic Neoplasms / diagnosis
-
Pancreatic Neoplasms / mortality
-
Pancreatic Neoplasms / pathology
-
Pancreatic Neoplasms / surgery*
-
Pancreatitis / diagnosis
-
Pancreatitis / mortality
-
Pancreatitis / pathology
-
Pancreatitis / surgery
-
Positron Emission Tomography Computed Tomography
-
Prognosis
-
Survival Rate
-
Tomography, X-Ray Computed